Claudio Laudani on PCSK9 Association with Increased Platelet Reactivity: A Pooled Analysis
Claudio Laudani, Cardiovascular Disease Fellow UNICT, Post-Doc Research Scholar UFHealth JAX, shared on LinkedIn:
”Circulating PCSK9 has been associated with increased platelet reactivity and adverse outcomes in patients with atherosclerotic cardiovascular disease.
However, the relative effects of additional PCSK9 inhibitions on platelet reactivity in patients on DAPT and chronic statin therapy has not been evaluated.
To answer this gap in knowledge, we performed a collaborative individual patient data meta-analysis of randomized controlled trials finding that, although PCSK9 inhibitors significantly reduced circulating lipoproteins, such reduction did not translate into any significant change in platelet reactivity at 4 weeks.
These results suggest that the effects of PCSK9 inhibitors are mostly related to plaque stabilization rather than an off-target effect on platelets.”
Read the full article here.
Article: Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled Studies
Authors: Luis Ortega-Paz, Yasushi Ueki, Claudio Laudani, Sylvain Losdat, Francesco Franchi, Ryota Kakizaki, Fabiana Rollini, Jonas Häner, Lorenz Räber, Dominick J. Angiolillo
Stay updated with Hemostasis Today.
-
May 22, 2026, 17:30Veronica Sanchez: Do You Live with Pain after a Stroke?
-
May 22, 2026, 17:25Maxime Dely: A Simple but Powerful Indicator of Platelet Quality
-
May 22, 2026, 17:24Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
-
May 22, 2026, 17:22Lucia Rugeri: Advancing Multidisciplinary Care for Heavy Menstrual Bleeding in Women with Bleeding Disorders
-
May 22, 2026, 17:20Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance
-
May 22, 2026, 16:26Sandeep De: Omicron COVID Infections Linked to Coronary Thrombosis without Detectable Plaque